BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19563409)

  • 1. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
    J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
    Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatocyte nuclear factor 4alpha in developing mice.
    Kanazawa T; Konno A; Hashimoto Y; Kon Y
    Anat Histol Embryol; 2009 Feb; 38(1):34-41. PubMed ID: 18803630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer.
    Yamagishi M; Noda M; Tatsumi Y; Mukaisho K; Mitsufuji S; Sugihara H; Okanoue T; Hattori T
    J Gastroenterol; 2004 Dec; 39(12):1143-9. PubMed ID: 15622477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
    Bailly A; Briançon N; Weiss MC
    Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
    Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype.
    Motoshita J; Nakayama H; Taniyama K; Matsusaki K; Yasui W
    Pathol Int; 2006 Apr; 56(4):200-5. PubMed ID: 16634965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.
    Ho SB; Shekels LL; Toribara NW; Kim YS; Lyftogt C; Cherwitz DL; Niehans GA
    Cancer Res; 1995 Jun; 55(12):2681-90. PubMed ID: 7780985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
    Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
    Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
    Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
    Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MUC13 is associated with intestinal-type gastric cancer.
    Shimamura T; Ito H; Shibahara J; Watanabe A; Hippo Y; Taniguchi H; Chen Y; Kashima T; Ohtomo T; Tanioka F; Iwanari H; Kodama T; Kazui T; Sugimura H; Fukayama M; Aburatani H
    Cancer Sci; 2005 May; 96(5):265-73. PubMed ID: 15904467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma.
    Li XL; Eishi Y; Bai YQ; Sakai H; Akiyama Y; Tani M; Takizawa T; Koike M; Yuasa Y
    Int J Oncol; 2004 Feb; 24(2):257-63. PubMed ID: 14719100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
    Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
    Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma.
    Naritomi K; Futami K; Arima S; Iwashita A
    Anticancer Res; 2003; 23(6a):4411-22. PubMed ID: 14666728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.